084853745	084853745	CD	B-NP	O
|	|	NN	I-NP	O
COH	COH	NN	I-NP	O
|	|	NN	I-NP	O
21746069	21746069	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9877082	9877082	CD	B-NP	O
|	|	CC	I-NP	O
11/11/2006	11/11/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
asthma	asthma	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/12/2006	2/12/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/10/2006	11/10/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
RUMBLE	RUMBLE	NNP	B-NP	O
,	,	,	O	O
LUPE	LUPE	NNP	B-NP	O
606-31-03-2	606-31-03-2	CD	I-NP	O
Washington	Washington	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
5/23/06	5/23/06	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KOETS	KOETS	NNP	B-NP	O
,	,	,	O	O
LEN	LEN	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALBUTEROL	ALBUTEROL	NN	B-NP	O
INHALER	INHALER	NN	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
NEBULIZER	NEBULIZER	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
NEB	NEB	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
11/19	11/19	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Shortness	Shortness	NNP	I-NP	O
of	of	IN	B-PP	O
Breath	Breath	NNP	B-NP	O
,	,	,	O	O
Wheezing	Wheezing	NNP	B-NP	O
ADVAIR	ADVAIR	NNP	I-NP	O
DISKUS	DISKUS	NNP	I-NP	O
500/50	500/50	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NN	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
COMBIVENT	COMBIVENT	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
AND	AND	CC	O	O
ALBUTEROL	ALBUTEROL	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
TID	TID	NN	I-NP	O
LISINOPRIL	LISINOPRIL	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/24/06	10/24/06	CD	B-NP	O
by	by	IN	B-PP	O
SICKEL	SICKEL	NNP	B-NP	O
,	,	,	O	O
SON	SON	NNP	B-NP	O
ORVILLE	ORVILLE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
228268145	228268145	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	B-protein
SINGULAIR	SINGULAIR	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
MONTELUKAST	MONTELUKAST	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
PREDNISONE	PREDNISONE	NNP	I-NP	I-protein
Taper	Taper	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Give	Give	NNP	I-NP	I-protein
60	60	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
q	q	NN	I-NP	I-protein
24	24	CD	I-NP	I-protein
h	h	NN	I-NP	I-protein
X	X	SYM	B-NP	I-protein
2	2	CD	I-NP	I-protein
dose	dose	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
s	s	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VB	B-VP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
3	3	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VB	B-VP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
3	3	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VB	B-VP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
3	3	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
3	3	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
Give	Give	VB	B-VP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
2	2	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Starting	Start	VBG	B-VP	O
IN	IN	IN	B-PP	O
AM	AM	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
11/25	11/25	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Activity	Activity	NN	B-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	O
arrange	arrange	NN	I-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Minium	Minium	NNP	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
AMOX	AMOX	NN	B-NP	O
.	.	.	O	O

/	/	SYM	O	B-protein
CLAV.ACID	CLAV.ACID	NN	B-NP	I-protein
250/125	250/125	CD	I-NP	I-protein
,	,	,	O	O
Codeine	Codeine	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Asthma	Asthma	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
asthma	asthma	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
asthma	asthma	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
asthma	asthma	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hyperglycemia	hyperglycemia	NN	I-NP	O
on	on	IN	B-PP	O
steriods	steriod	NNS	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
elevated	elevated	JJ	I-NP	O
glucose	glucose	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hirsutism	hirsutism	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hirsutism	hirsutism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
spinal	spinal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
spinal	spinal	JJ	I-NP	B-protein
stenosis	stenosis	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
LBP	LBP	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	O
low	low	JJ	I-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
chiari	chiari	NN	I-NP	O
malformation	malformation	NN	I-NP	O
spinal	spinal	JJ	I-NP	O
syrinx	syrinx	NN	I-NP	O
C3-T2	C3-T2	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
8	8	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
42	42	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
h/o	h/o	NN	I-NP	B-protein
asthma	asthma	NN	I-NP	I-protein
p/w	p/w	NN	I-NP	I-protein
SOB	SOB	NN	I-NP	I-protein
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
recent	recent	JJ	B-NP	O
asthma	asthma	NN	I-NP	O
flare	flare	NN	I-NP	O
******************	******************	SYM	B-NP	O
Pt	Pt	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
USOH	USOH	NN	I-NP	B-protein
until	until	IN	B-PP	O
1wk	1wk	NN	B-NP	O
PTA	PTA	NN	I-NP	O
when	when	WRB	B-ADVP	O
experienced	experienced	JJ	B-NP	O
URI	URI	NN	I-NP	O
sx	sx	NN	I-NP	O
,	,	,	O	O
productive	productive	JJ	B-NP	O
cough	cough	NN	I-NP	O
and	and	CC	O	O
low	low	JJ	B-NP	O
grade	grade	NN	I-NP	O
fevers	fever	NNS	I-NP	O
.	.	.	O	O

Seen	Seen	NNP	B-NP	O
at	at	IN	B-PP	O
Tasleyka	Tasleyka	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
where	where	WRB	B-ADVP	O
rx	rx	NN	B-NP	O
'd	'd	VBD	B-VP	O
with	with	IN	B-PP	O
nebs	neb	NNS	B-NP	O
,	,	,	O	O
steroids	steroid	NNS	B-NP	O
and	and	CC	O	O
d/c	d/c	NN	B-NP	O
'd	'd	VBP	B-VP	O
on	on	IN	B-PP	O
pred	pred	JJ	B-NP	O
taper	taper	NN	I-NP	O
starting	start	VBG	B-VP	O
at	at	IN	B-PP	O
40mg	40mg	CD	B-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
told	tell	VBN	I-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
CXR	CXR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
c/w	c/w	NN	B-NP	O
PNA	PNA	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-NP	O
rx	rx	NN	I-NP	O
'd	'd	MD	B-VP	O
Z-pack	Z-pack	NN	I-VP	B-protein
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
completed	complete	VBN	I-VP	O
.	.	.	O	O

Cough	Cough	NN	B-NP	O
and	and	CC	I-NP	O
URI	URI	NN	I-NP	O
sx	sx	NN	I-NP	O
have	have	VBP	B-VP	O
improved	improve	VBN	I-VP	O
but	but	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
persistent	persistent	JJ	B-NP	O
DOE	DOE	NNP	I-NP	O
.	.	.	O	O

Peak	Peak	NN	B-NP	O
flow	flow	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
150	150	CD	B-NP	O
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
of	of	IN	B-PP	O
300-350	300-350	CD	B-NP	O
.	.	.	O	O

Seen	Seen	NN	B-NP	O
in	in	IN	B-PP	O
TNH	TNH	NN	B-NP	O
urgent	urgent	JJ	I-NP	O
care	care	NN	I-NP	O
today	today	NN	B-NP	O
where	where	WRB	B-ADVP	O
reportedly	reportedly	RB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
hypertensive	hypertensive	JJ	B-ADJP	O
and	and	CC	O	O
O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
94-95	94-95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	O
,	,	,	O	O
referred	refer	VBN	B-VP	O
to	to	TO	B-PP	O
OAKMA	OAKMA	NN	B-NP	O
VALLEY	VALLEY	NN	I-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
for	for	IN	B-PP	O
asthma	asthma	NN	B-NP	O
flare	flare	NN	I-NP	O
refractory	refractory	JJ	B-ADJP	O
to	to	TO	B-PP	O
current	current	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
HA	HA	NN	B-NP	O
or	or	CC	O	O
focal	focal	JJ	B-NP	O
neurological	neurological	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
c/o	c/o	NN	I-NP	O
+	+	SYM	B-NP	O
increased	increase	VBD	B-VP	O
LE	LE	NN	B-NP	B-protein
edema	edema	NN	I-NP	I-protein
L	L	NN	I-NP	I-protein
>	>	SYM	O	I-protein
R	R	NNP	B-NP	O
,	,	,	O	O
+	+	JJ	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
+	+	JJ	B-NP	O
PND	PND	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
sick	sick	JJ	I-NP	O
contacts	contact	NNS	I-NP	O
.	.	.	O	O

****	****	SYM	B-NP	O
ED	ED	NN	I-NP	O
:	:	:	O	O
97.4	97.4	CD	B-NP	O
p126	p126	NN	I-NP	B-protein
181/95	181/95	CD	B-NP	I-protein
30	30	CD	I-NP	I-protein
94	94	CD	I-NP	I-protein
%	%	NN	I-NP	I-protein
RA	RA	NN	I-NP	I-protein
,	,	,	O	O
CXR	CXR	NN	B-NP	B-protein
and	and	CC	I-NP	O
EKG	EKG	NN	I-NP	B-protein
performed	perform	VBN	B-VP	O
,	,	,	O	O
rx	rx	NN	B-NP	O
'd	'd	MD	B-VP	O
prednisone	prednisone	NN	B-NP	O
60mg	60mg	NN	I-NP	O
x1	x1	NN	I-NP	O
,	,	,	O	O
nebs	neb	NNS	B-NP	O
.	.	.	O	O

**************	**************	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
Asthma	Asthma	NN	B-NP	O
-	-	:	O	O
no	no	DT	B-NP	O
h/o	h/o	NN	I-NP	O
intubation	intubation	NN	I-NP	O
,	,	,	O	O
multiple	multiple	JJ	B-NP	O
admissions	admission	NNS	I-NP	O
and	and	CC	I-NP	O
courses	course	NNS	I-NP	O
of	of	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
Obesity	Obesity	NN	B-NP	O
,	,	,	O	O
Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
,	,	,	O	O
Hyperglycemia	Hyperglycemia	NN	B-NP	O
-	-	HYPH	O	O
when	when	WRB	B-ADVP	O
on	on	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
,	,	,	O	O
Hirsutism	Hirsutism	NNP	B-NP	O
,	,	,	O	O
Chiari	Chiari	NNP	B-NP	O
Malformation	Malformation	NNP	I-NP	O
-	-	HYPH	B-NP	O
s/p	s/p	NN	I-NP	O
decompression	decompression	NN	I-NP	O
,	,	,	O	O
Spinal	Spinal	NNP	B-NP	O
Stenosis	Stenosis	NNP	I-NP	O
,	,	,	O	O
Spinal	Spinal	NNP	B-NP	O
Syrinx	Syrinx	NNP	I-NP	O
-	-	HYPH	B-NP	O
C3-T2	C3-T2	NN	I-NP	B-protein
,	,	,	O	O
Low	Low	NNP	B-NP	O
back	back	RB	B-ADVP	O
pain	pain	NN	B-NP	O
-	-	HYPH	I-NP	O
s/p	s/p	NN	I-NP	O
multiple	multiple	JJ	I-NP	O
epidural	epidural	JJ	I-NP	O
steroid	steroid	NN	I-NP	O
injections	injection	NNS	I-NP	O
*************	*************	SYM	B-NP	O
MEDS	MEDS	NN	I-NP	O
:	:	:	O	O
prednisone	prednisone	NN	B-NP	O
30mg	30mg	CD	I-NP	O
qd	qd	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
taper	taper	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
advair	advair	NN	B-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
,	,	,	O	O
combivent	combivent	NN	B-NP	O
,	,	,	O	O
singulair	singulair	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
***********	***********	SYM	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
Afeb	Afeb	NN	B-NP	O
p104	p104	NN	I-NP	O
199/104	199/104	CD	B-NP	O
rr25	rr25	CD	I-NP	O
96	96	CD	I-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
Pt	Pt	NN	I-NP	O
appeared	appear	VBD	B-VP	O
in	in	IN	B-PP	O
mild	mild	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
sitting	sit	VBG	B-VP	O
up	up	RP	B-PRT	O
reading	read	VBG	B-VP	O
a	a	DT	B-NP	O
book	book	NN	I-NP	O
,	,	,	O	O
very	very	RB	B-NP	O
pleasant	pleasant	JJ	I-NP	O
obese	obese	JJ	I-NP	O
woman	woman	NN	I-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	B-protein
not	not	RB	O	O
elevated	elevated	JJ	B-NP	O
LUNGS	LUNGS	NN	I-NP	O
:	:	:	O	O
prolonged	prolonged	JJ	B-NP	O
expiratory	expiratory	JJ	I-NP	O
phase	phase	NN	I-NP	O
CVS	CVS	NN	I-NP	O
:	:	:	O	O
rrr	rrr	NN	B-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	B-protein
S1S2	S1S2	NN	I-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
m/g/r	m/g/r	NN	I-NP	O
ABD	ABD	NN	I-NP	O
:	:	:	O	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
BS	BS	NN	I-NP	O
+	+	SYM	B-NP	O
,	,	,	O	O
NT/ND	NT/ND	NN	B-NP	O
EXT	EXT	NN	I-NP	O
:	:	:	O	O
TR	TR	NN	B-NP	B-protein
to	to	TO	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
to	to	TO	B-PP	O
mid	mid	JJ	B-NP	O
calf	calf	NN	I-NP	O
bilat	bilat	NN	I-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
>	>	SYM	B-NP	O
R	R	NN	I-NP	B-protein
***************	***************	SYM	I-NP	I-protein
LABS	LABS	NN	I-NP	I-protein
:	:	:	O	O
WBC	WBC	NN	B-NP	O
14	14	CD	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
EKG	EKG	NN	B-NP	O
:	:	:	O	O
sinus	sinus	NN	B-NP	O
tach	tach	NN	I-NP	O
104	104	CD	I-NP	O
CXR	CXR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
:	:	:	O	O
linear	linear	JJ	B-NP	O
opacity	opacity	NN	I-NP	O
in	in	IN	B-PP	O
RLL	RLL	NN	B-NP	B-cell_line
most	most	RBS	B-NP	O
c/w	c/w	JJ	I-NP	O
platelike	platelike	JJ	I-NP	O
atelectasis	atelectasis	NN	I-NP	O
but	but	CC	O	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
r/o	r/o	VB	I-VP	O
resolving	resolve	VBG	I-VP	O
or	or	CC	O	O
new	new	JJ	B-NP	O
PNA	PNA	NN	I-NP	O
***************	***************	SYM	B-NP	O
HOSITAL	HOSITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
42	42	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
asthma	asthma	NN	B-NP	O
and	and	CC	I-NP	O
tobacco	tobacco	NN	I-NP	O
use	use	NN	I-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
asthma/COPD	asthma/COPD	NN	B-NP	O
flare	flare	NN	I-NP	O
refractory	refractory	JJ	B-ADJP	O
to	to	TO	B-PP	O
initial	initial	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
*	*	SYM	B-NP	O
PULM	PULM	NN	I-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	B-protein
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
2/2	2/2	CD	B-NP	O
reactive	reactive	JJ	I-NP	O
airway	airway	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Substantial	Substantial	JJ	B-NP	O
smoking	smoking	NN	I-NP	O
history	history	NN	I-NP	O
raises	raise	VBZ	B-VP	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
COPD	COPD	NN	B-NP	O
as	as	IN	B-PP	O
contributor	contributor	NN	B-NP	O
or	or	CC	O	O
dominant	dominant	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
duonebs	duoneb	NNS	B-NP	O
q4h	q4h	NN	I-NP	O
with	with	IN	B-PP	O
Albuterol	Albuterol	NN	B-NP	O
q2h	q2h	NN	I-NP	O
prn	prn	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
advair	advair	NN	B-NP	O
,	,	,	O	O
singulair	singulair	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Prednisone	Prednisone	NN	B-NP	O
60	60	CD	I-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
4	4	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
then	then	RB	B-VP	O
slowy	slowy	RB	I-VP	O
tapered	taper	VBN	I-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
abx	abx	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
just	just	RB	B-ADVP	O
completed	complete	VBD	B-VP	O
course	course	NN	B-NP	O
.	.	.	O	O

WBC	WBC	NN	B-NP	O
elevation	elevation	NN	I-NP	O
likely	likely	RB	B-ADJP	O
2/2	2/2	CD	B-NP	O
steroids	steroid	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
D/C	D/C	NN	B-NP	O
,	,	,	O	O
peak	peak	NN	B-NP	O
flow	flow	NN	I-NP	O
had	have	VBD	B-VP	O
improved	improve	VBN	I-VP	O
to	to	TO	B-PP	O
250	250	CD	B-NP	O
and	and	CC	O	O
ambulating	ambulate	VBG	B-VP	O
O2	O2	NN	B-NP	O
sat	sat	NN	I-NP	O
was	be	VBD	B-VP	O
92-94	92-94	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
's	's	POS	B-NP	O
breathing	breathing	NN	I-NP	O
had	have	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
improved	improve	VBN	I-VP	O
.	.	.	O	O

Smoking	Smoking	NN	B-NP	O
cessation	cessation	NN	I-NP	O
encouraged	encourage	VBD	B-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
interested	interested	JJ	B-ADJP	O
in	in	IN	B-PP	O
trying	try	VBG	B-VP	O
nicotine	nicotine	NN	B-NP	O
patch	patch	NN	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
PUMP	PUMP	NN	B-NP	O
:	:	:	O	O
HTN	HTN	NN	B-NP	O
:	:	:	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-VP	O
20mg	20mg	VB	I-VP	O
daily	daily	RB	B-ADVP	O
due	due	IN	B-PP	O
to	to	TO	I-PP	O
hypertension	hypertension	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
end-organ	end-organ	JJ	B-NP	O
damage	damage	NN	I-NP	O
in	in	IN	B-PP	O
w/u	w/u	NN	B-NP	O
.	.	.	O	O

UA	UA	NN	B-NP	O
neg	neg	NN	I-NP	O
for	for	IN	B-PP	O
proteinuria	proteinuria	NN	B-NP	O
.	.	.	O	O

*	*	SYM	O	O
PPX	PPX	NN	B-NP	B-protein
:	:	SYM	I-NP	O
lovenox	lovenox	NN	I-NP	O
CODE	CODE	NN	I-NP	O
:	:	:	O	O
full	full	JJ	B-NP	O
ADDITIONAL	ADDITIONAL	JJ	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Continue	Continue	VB	B-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-VP	O
20mg	20mg	VB	I-VP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Take	Take	VB	B-VP	O
prednisone	prednisone	NN	B-NP	O
60mg	60mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
starting	start	VBG	I-NP	O
tomorrow	tomorrow	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
then	then	RB	O	O
50mg	50mg	CD	B-NP	O
daily	daily	JJ	I-NP	O
x	x	NN	I-NP	O
3days	3day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	O	O
40mg	40mg	CD	B-NP	O
daily	daily	JJ	I-NP	O
x3	x3	NN	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	O	O
30mg	30mg	CD	B-NP	O
daily	daily	JJ	I-NP	O
x	x	NN	I-NP	O
3days	3day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	O	O
20mg	20mg	CD	B-NP	O
daily	daily	JJ	I-NP	O
x3	x3	NN	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	O	O
10mg	10mg	CD	B-NP	O
daily	daily	JJ	I-NP	O
x2	x2	NN	I-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
stop	stop	VB	B-VP	O
.	.	.	O	O

3	3	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Please	Please	NN	B-NP	O
arrnge	arrnge	NN	I-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Portune	Portune	NNP	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
advise	advise	VB	I-VP	O
you	you	PRP	B-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Call	Call	NNP	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Schmatz	Schmatz	NNP	I-NP	O
or	or	CC	O	O
come	come	VB	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
experience	experience	VBP	B-VP	O
worsening	worsen	VBG	I-VP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
breathing	breathing	NN	I-NP	O
or	or	CC	I-NP	O
fever	fever	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
**	**	SYM	B-NP	O
Dr.	Dr.	NNP	B-NP	O
Tremmel	Tremmel	NNP	I-NP	O
**	**	NNP	I-NP	O
Please	Please	NNP	I-NP	O
taper	taper	NN	I-NP	O
prednisone	prednisone	NN	I-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
by	by	IN	B-PP	O
patient	patient	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
DANIELS	DANIELS	NN	B-NP	O
,	,	,	O	O
BOB	BOB	NN	B-NP	B-protein
T	T	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
MN92	MN92	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
5/23/06	5/23/06	CD	I-NP	O
@	@	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

